Overview
The Technologies Dashboard provides a high-level overview of the technology landscape for neurodegenerative disease research and treatment. This page serves as a navigation hub for finding technologies by category, development stage, and therapeutic application. [@neurotechnology2024]
Quick Stats
| Metric | Value |
|--------|-------|
| Total Technology Pages | 104 |
| AI/ML Tools | ~15 |
| Brain-Computer Interfaces | ~10 |
| Imaging Technologies | ~20 |
| Therapeutic Devices | ~15 |
| Research Tools | ~40 |
Navigation
By Category
- [Technology Overview](/technologies/overview) — Introduction and landscape analysis
- [Technology Rankings](/technologies/rankings) — Ranked technologies by potential and stage
By Application
- Diagnostic Technologies: [AI-Decoded Neural Intent BCI](/technologies/ai-decoded-neural-intent-bci), [PET Imaging](/technologies/pet-imaging), [MR Spectroscopy](/technologies/mr-spectroscopy)
- Therapeutic Technologies: [Deep Brain Stimulation](/therapeutics/deep-brain-stimulation), [Gene Therapy](/therapeutics/gene-therapy), [AAV Vectors](/technologies/aav-vectors)
- Research Tools: [AlphaFold](/technologies/alphafold), [Allen Brain Atlas](/technologies/allen-brain-atlas-api), [Organoid Models](/technologies/brain-organoids)
Brain-Computer Interfaces (BCIs)
- [ALS Communication BCI](/technologies/als-communication-bci)
- [BCI-Assisted Rehabilitation](/technologies/bci-rehabilitation)
- [Biointegrated Neural Interfaces](/technologies/biointegrated-neural-interfaces)
Featured Technologies
Highest Impact
Gene Therapy — Highest therapeutic potential for monogenic neurodegenerative diseases
CRISPR-Cas9 — Emerging gene editing technology with high long-term potential
Deep Brain Stimulation (DBS) — Proven therapeutic for PD tremor and motor symptomsMost Active Development
AAV Vectors — Gene delivery platform in multiple clinical trials
BBB Crossing Technologies — Enabling CNS drug delivery
Digital Therapeutics — Software-based interventions for cognitive enhancementRecent Updates
- Added 5 new BCI technology pages (2026-03)
- Updated AI/ML tool rankings with new research
- Expanded therapeutic device coverage
- [Biomarkers](/biomarkers) — Companion diagnostic technologies
- [Treatments](/therapeutics) — Therapeutic interventions
- [Mechanisms](/mechanisms) — Disease mechanisms targeted by technologies
See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
- [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)
Technology Categories
Artificial Intelligence and Machine Learning
AI and machine learning technologies are transforming neurodegenerative disease research through improved diagnostic accuracy, prognostic modeling, and drug discovery.
Neural Network Architectures: Deep learning models including convolutional neural networks (CNNs) for image analysis, recurrent neural networks (RNNs) for time-series data, and transformer models for natural language processing. These architectures enable automated analysis of MRI scans, prediction of disease progression, and extraction of insights from electronic health records.
Machine Learning for Biomarker Discovery: ML algorithms identify patterns in multi-omic data (genomics, proteomics, metabolomics) to discover novel biomarkers for early diagnosis and disease monitoring. Support vector machines, random forests, and neural networks are commonly applied to distinguish disease states from healthy controls.
Natural Language Processing: NLP technologies extract structured information from scientific literature, clinical notes, and research papers to build knowledge graphs and assist literature review. See [AI Literature Mining](/technologies/ai-literature-mining).
Brain-Computer Interfaces
BCIs provide direct communication pathways between the brain and external devices, offering both diagnostic and therapeutic applications.
Invasive BCIs: Electrode arrays implanted in the motor [cortex](/brain-regions/cortex) enable control of prosthetic limbs and computers. Companies like Neuralink and Synchron are developing implantable devices for patients with paralysis and movement disorders.
Non-Invasive BCIs: EEG-based BCIs and functional near-infrared spectroscopy (fNIRS) provide safer alternatives for research and clinical applications. These technologies are used for neurofeedback training and cognitive rehabilitation.
Neural Recording Technologies: High-density electrode arrays and emerging technologies like carbon fiber electrodes enable long-term recording of neural activity with single-neuron resolution. See [Neural Recording](/technologies/neural-recording).
Imaging Technologies
Advanced imaging technologies enable visualization of brain structure, function, and molecular pathology.
Positron Emission Tomography (PET): PET imaging with amyloid and [tau](/proteins/tau) tracers enables in vivo visualization of protein pathology. New tracers for [alpha-synuclein](/proteins/alpha-synuclein) and neuroinflammation are in development. See [PET Imaging](/technologies/pet-imaging).
Magnetic Resonance Imaging (MRI): Advanced MRI techniques including diffusion tensor imaging (DTI), functional MRI (fMRI), and magnetic resonance spectroscopy (MRS) provide insights into brain connectivity, activity, and metabolism. See [MRI Technologies](/technologies/mr-imaging).
Optical Imaging: Two-photon microscopy enables visualization of neuronal activity and pathology in animal models. Label-free techniques like coherent anti-Stokes Raman scattering (CARS) detect protein aggregates without staining.
Therapeutic Devices
Deep Brain Stimulation (DBS): Implanted electrodes deliver electrical stimulation to specific brain regions, improving motor symptoms in Parkinson's disease and essential tremor. New closed-loop systems adapt stimulation based on neural activity. See [Deep Brain Stimulation](/therapeutics/deep-brain-stimulation).
Transcranial Magnetic Stimulation (TMS): Non-invasive brain stimulation modulates cortical excitability. Repetitive TMS (rTMS) is being investigated for cognitive enhancement in Alzheimer's disease.
Focused Ultrasound: High-intensity focused ultrasound (HIFU) enables non-invasive lesioning of specific brain regions and targeted drug delivery across the [blood-brain barrier](/entities/blood-brain-barrier).
Technology Readiness Levels
NeuroWiki categorizes technologies by development stage using a modified technology readiness level (TRL) scale:
| TRL | Description | Examples |
|-----|-------------|----------|
| 1-3 | Basic research | Novel biomarkers, early AI models |
| 4-6 | Development | Clinical trials, FDA approvals |
| 7-9 | Deployment | Approved therapies, widespread adoption |
Emerging Technologies to Watch
Optogenetics: Light-based control of [neurons](/entities/neurons) genetically modified to express light-sensitive ion channels. Currently limited to research but may enable precise neural circuit manipulation.
Gene Editing: CRISPR and other gene editing technologies enable correction of disease-causing mutations. Clinical trials for Huntington's disease and ALS are underway.
Cell Therapy: Stem cell-derived neurons and glial cells may replace lost cells and provide neurotrophic support. Clinical trials for Parkinson's disease are progressing.
Digital Therapeutics: Software-based interventions for cognitive training, symptom monitoring, and behavior modification. FDA-approved apps for Alzheimer's and Parkinson's are emerging.
References
[Unknown, Neurotechnology advances in neurodegeneration (2024) (2024)](https://doi.org/10.1016/j.neurotherapeutics.2024.01.001)